BC
VRNA

BIT Capital’s Verona Pharma VRNA Stock Holding History

BIT Capital’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,407
Closed -$343K – 122
2025
Q1 		$343K Sell
5,407
-26,423
-83% -$1.58M 0.03% 85
2024
Q4 		$1.48M Sell
31,830
-199,373
-86% -$7.49M 0.12% 63
2024
Q3 		$6.65M Sell
231,203
-91,667
-28% -$2.26M 0.62% 32
2024
Q2 		$4.67M Sell
322,870
-31,278
-9% -$457K 0.37% 37
2024
Q1 		$5.7M Buy
354,148
+266,844
+306% +$4.61M 0.42% 43
2023
Q4 		$1.74M Buy
87,304
+71,804
+463% +$1.06M 0.17% 51
2023
Q3 		$253K Buy
15,500
+2,500
+19% +$48.1K 0.03% 80
2023
Q2 		$275K Hold
13,000
– – 0.03% 103
2023
Q1 		$261K Buy
13,000
+9,500
+271% +$205K 0.04% 104
2022
Q4 		$91.5K Buy
+3,500
New +$46.6K 0.02% 123

Other funds holding VRNA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BIT Capital's VRNA Position: Q2 2025 in Review

BIT Capital sold out of Verona Pharma (VRNA) in Q2 2025, closing a stake of 5,407 shares — an estimated $343K sold.

BIT Capital first reported a position in VRNA in Q4 2022 and held it in 10 quarters. The position peaked at $6.65M in Q3 2024. 292 funds tracked by Wall St. Rank hold VRNA as of Q2 2025.

  • BIT Capital reported no remaining Verona Pharma position as of Q2 2025 after selling out during the quarter.
  • BIT Capital sold 5,407 Verona Pharma shares in Q2 2025, an estimated $343K.
  • BIT Capital first reported a position in Verona Pharma in Q4 2022 and held it in 10 quarters.
  • BIT Capital's Verona Pharma position peaked at $6.65M in Q3 2024.
  • 292 funds tracked by Wall St. Rank held Verona Pharma as of Q2 2025.

Based on BIT Capital's 13F filing for Q2 2025, filed 8 Aug 2025.